NDC 00173-696 - ADVAIR DISKUS
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 00173-696
- Manufacturer
- Rebel Distributors Corp.
- Effective date
- 2010-09-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ADVAIR DISKUS - Rebel Distributors Corp. | Rebel Distributors Corp. | 2010-09-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FLUTICASONE PROPIONATE | ACTIVE INGREDIENT | O2GMZ0LF5W | ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REBEL DISTRIBUTORS CORP.] | 1 | |
| SALMETEROL XINAFOATE | ACTIVE INGREDIENT | 6EW8Q962A5 | ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REBEL DISTRIBUTORS CORP.] | 1 | |
| FLUTICASONE | ACTIVE MOIETY | CUT2W21N7U | ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REBEL DISTRIBUTORS CORP.] | 1 | |
| SALMETEROL | ACTIVE MOIETY | 2I4BC502BT | ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REBEL DISTRIBUTORS CORP.] | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REBEL DISTRIBUTORS CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fluticasone propionate and salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | REMEDYREPACK INC. | 7fecae39-f966-4da5-99f6-4d9428d1b147 | 2026-06-11 | Warnings, Adverse reactions | 896209 6EW8Q962A5 O2GMZ0LF5W |
| FLUTICASONE PROPIONATE | FLUTICASONE PROPIONATE | Preferred Pharmaceuticals Inc. | 8225d521-f1f7-4d21-9095-9a2e1833d1bf | 2026-06-08 | Warnings, Adverse reactions | O2GMZ0LF5W |
| allergy relief nasal | FLUTICASONE PROPIONATE | HyVee Inc | c3327be1-e4a9-4b02-968d-eff5e18cbc84 | 2026-06-03 | Warnings | O2GMZ0LF5W |
| allergy nasal | FLUTICASONE PROPIONATE | Rite Aid Corporation | e471dacd-9b6e-4783-9a14-aa95d00cbc9c | 2026-06-03 | Warnings | O2GMZ0LF5W |
| FLUTICASONE PROPIONATE | FLUTICASONE PROPIONATE | YYBA Corp | 5333562e-9d8e-2618-e063-6394a90a8673 | 2026-06-01 | Warnings | O2GMZ0LF5W |
| Allergy Relief | FLUTICASONE PROPIONATE | P & L Development, LLC | f83fabaa-1c6c-4a19-9f30-2f06df6d48f4 | 2026-05-26 | Warnings | O2GMZ0LF5W |
| Mucinex Nasal Congestion and Allergy Relief | FLUTICASONE PROPIONATE | Reckitt Benckiser LLC | 47d8bb65-0bff-f24d-e063-6394a90affaf | 2026-05-20 | Warnings | O2GMZ0LF5W |
| Equate Childrens Allergy Relief | FLUTICASONE PROPIONATE | WALMART INC. | 7e6949aa-66a7-4288-9990-3ad2ece1df3d | 2026-05-19 | Warnings | O2GMZ0LF5W |
| XHANCE | FLUTICASONE PROPIONATE | Paratek Pharmaceuticals, Inc. | 44fcea33-8cfa-3a5c-e063-6394a90aafb2 | 2026-05-19 | Warnings, Adverse reactions | O2GMZ0LF5W |
| FLUTICASONE PROPIONATE DISKUS | FLUTICASONE PROPIONATE | A-S Medication Solutions | da4e897e-9be1-499a-8889-15398b30ef3b | 2026-05-14 | Warnings, Adverse reactions | O2GMZ0LF5W |
| Fluticasone Propionate ALLERGY RELIEF | FLUTICASONE PROPIONATE | GLENMARK THERAPEUTICS INC., USA | 5494106f-6792-409e-b63f-b63b98140959 | 2026-05-05 | Warnings | O2GMZ0LF5W |
| Fluticasone Propionate | FLUTICASONE PROPIONATE | Allegiant Health | f4b9fcfc-f3f7-4ce0-8f97-3d475081aa67 | 2026-04-29 | Warnings | O2GMZ0LF5W |
| childrens allergy relief | FLUTICASONE PROPIONATE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 4b1d223a-723b-4569-9505-da727691bc56 | 2026-04-29 | Warnings | O2GMZ0LF5W |
| ADVAIR DISKUS | FLUTICASONE PROPIONATE AND SALMETEROL | A-S Medication Solutions | cf306656-0d4c-4edd-9d6a-3471f99484e6 | 2026-04-26 | Warnings, Adverse reactions | NDA021077 896229 896228 896212 896209 6EW8Q962A5 O2GMZ0LF5W |
| CareOne Allergy Relief | FLUTICASONE PROPIONATE | American Sales Company | 587d7c72-a70e-4ada-945d-14989b96350c | 2026-04-23 | Warnings | O2GMZ0LF5W |
| careone childrens allergy relief | FLUTICASONE PROPIONATE | American Sales Company | 45ffaf45-8b88-44ba-804b-c2b563589898 | 2026-04-23 | Warnings | O2GMZ0LF5W |
| Fluticasone Propionate | FLUTICASONE PROPIONATE | Preferred Pharmaceuticals Inc. | 0a3447a1-407c-40a8-99bb-7e9a86eb37df | 2026-04-22 | Warnings, Adverse reactions | O2GMZ0LF5W |
| Fluticasone Propionate | FLUTICASONE PROPIONATE | Preferred Pharmaceuticals, Inc. | 4916301d-bcc8-4cd1-86b4-7bf0aecfbf68 | 2026-04-22 | Warnings, Adverse reactions | O2GMZ0LF5W |
| Up and Up Allergy Relief Nasal | FLUTICASONE PROPIONATE | Target Corporation | 51c0a953-93cb-4d0a-b51c-02d9482d1746 | 2026-04-20 | Warnings | O2GMZ0LF5W |
| Good Sense 24 hour allergy nasal | FLUTICASONE PROPIONATE | L. Perrigo Company | 783ce1b9-27e4-428a-9f5e-04e70b234ac9 | 2026-04-09 | Warnings | O2GMZ0LF5W |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.